Literature DB >> 7682462

The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects.

M Denijn1, D J Ruiter.   

Abstract

In this review, we present a literature survey of angiogenesis in melanoma. Progression in melanoma is supposed to be associated with an angiogenic response. Several histological studies have shown an increase of vascular structures in malignant melanoma, which is not the case in common naevocellular naevi. Neovascularization can be caused by several angiogenic factors: the most important of those produced in melanoma are described. Proteases such as urokinase plasminogen activator and metalloproteinases are important for the migration for both endothelial cells and tumour cells. Possible effects of these factors in melanoma cells are discussed. Finally, inhibition of angiogenesis and its potential role in melanoma therapy are considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682462     DOI: 10.1097/00008390-199304000-00002

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

1.  Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.

Authors:  Einar K Rofstad; Berit Mathiesen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

Authors:  P Lin; P Polverini; M Dewhirst; S Shan; P S Rao; K Peters
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.

Authors:  E J Battegay
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

4.  Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.

Authors:  K J Busam; M Berwick; K Blessing; K Fandrey; S Kang; T Karaoli; J Fine; A J Cochran; W L White; J Rivers
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

5.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

6.  Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.

Authors:  Goutam Chakraborty; Santosh Kumar; Rosalin Mishra; Tushar V Patil; Gopal C Kundu
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

7.  Enhanced expression of vascular endothelial growth factor in metastatic melanoma.

Authors:  P Salven; P Heikkilä; H Joensuu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.